ArticleMolecular cancer therapeutics2018

Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer.

Alexander Beatty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.